Research Summary

IBRI DIABETES CENTER (IDC)

Focus: The molecular basis of diabetes

Researchers in the IBRI Diabetes Center (IDC) focus on the molecular basis of diabetes and its complications, including mechanisms for beta cell regeneration. The IDC is highly collaborative and structured to support basic science research seeking to understand the disease while achieving technological breakthroughs in the way we diagnose, treat and manage diabetes in Indiana and beyond.

The IDC includes the lab of the center Director, Robert Considine, Ph.D., the Considine Lab, the Lilly Diabetes Center of Excellence (LDCE), a collaboration between Eli Lilly and Company, Indiana University School of Medicine and the IBRI, and the Regenerative Medicine and Metabolic Biology (RMMB) group.

The IDC aims to become a nexus of strategically aligned basic diabetes research in Indianapolis and the state. 

 

Lab Team